Xeris Pharmaceuticals, Inc. Announces Dosing of First Patient in Phase 2 …

Published April 26, 2014

Xeris Pharmaceuticals, Inc. Announces Dosing of First Patient in Phase 2 …
Austin, Texas, April 24, 2014 (GLOBE NEWSWIRE) — Xeris Pharmaceuticals, Inc. ("Xeris"), a clinical stage, specialty biopharmaceutical company developing novel, non-aqueous formulations of injectable drugs, announced today the dosing of the first …
Read more on GlobeNewswire (press release)

MD Anderson Leverages IBM Watson in Cancer-Fighting Efforts
Mike Rhodin, senior vice president for IBM's Watson Group, was in Austin Wednesday meeting with staff in the group's emerging technologies and strategies departments. The Texas capital is a key node in Watson, IBM's big artificial intelligence project, …
Read more on Xconomy

Promising Novel Pertussis Therapy Developed by Biotech Forms Synthetic …
Promising Novel Pertussis Therapy Developed by Biotech Forms Synthetic Biologics And Intrexon Inc. With UT Austin Researchers. Posted by: Charles … Agency of Canada. As of January 2014, 424 pertussis cases had already been reported in Texas this year …
Read more on BioNews Texas

90 Day Gender Specific Drug and Alcohol Rehab Program: Austin, Texas – Benchmark Recovery Center — Visit Our Website http://www.benchmarkcenter.com/

Find More Drug Treatment Centers Austin Texas Information…